Clinical Status
A versatile clinical pipeline spanning BBB opening alone, combination therapies with drugs, and non-invasive neuromodulation across a broad range of neurological disorders and metabolic diseases.
We are currently conducting clinical trials in Alzheimer’s disease, with encouraging clinical outcomes to date, as well as in recurrent glioblastoma (rGBM) in combination with chemotherapy.
Strategic Collaboration
Neumous is open to strategic collaborations with global pharmaceutical companies seeking innovative approaches to enhance drug delivery to the brain through focused ultrasound.